Endoscopic ultrasonography-guided fine-needle aspiration biopsy (EUS-FNAB) has been
shown to be a highly accurate technique for distinguishing benign from malignant pancreatic …

Background: Pancreatic ductal carcinoma (PDC) is one of the most lethal human
carcinomas. Expression patterns of some genes may predict gemcitabine (GEM) treatment …

Objectives The accuracy of endoscopic ultrasound-fine needle aspiration cytology (EUS-
FNAC) for the diagnosis of pancreatic cancer is suboptimal. Mutational activation of the kras …

Precision medicine in cancer treatment refers to targeted therapy based on the evaluation of
biomarkers. Although precision medicine for pancreatic cancer (PC) remains challenging …

Background The differentiation between benign and malignant abdominal lymph nodes is
difficult, especially if no primary site is evident or if cancer resection was remote in time. The …

Aim: To establish the usefulness of KRAS mutational analysis in the diagnosis of pancreatic
adenocarcinoma by comparing this technique with conventional cytology in aspirates …

Even though the cytologic criteria for pancreatic ductal adenocarcinoma (PDA) on fine-
needle aspiration biopsy (FNAB) specimens have been well defined, a diagnostic challenge …

Pancreatic ductal adenocarcinoma (PDAC) is the fourth and fifth leading cause of cancer
death for each gender in developed countries. With lack of effective treatment and screening …

OBJECTIVES: Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB) is
a useful tool in the diagnosis of pancreatic masses. Genetic analysis of these samples could …

Background Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) technology is
widely used for the diagnosis of pancreatic masses. However, in some cases, inadequate …